Second-line Treatment of Stage III/IV Non-Small-Cell Lung Cancer (NSCLC) with pemetrexed in routine clinical practice: Evaluation of performance status and health-related quality of life

BACKGROUND: Second-line treatment of advanced non-small-cell lung cancer (NSCLC) improves overall survival. There is a lack of data regarding the impact on patients' overall health condition. This prospective, non-interventional study evaluated performance status (PS) and health-related quality...

Descripción completa

Detalles Bibliográficos
Autores principales: Schuette, Wolfgang, Tesch, Hans, Büttner, Hartwig, Krause, Thomas, Soldatenkova, Victoria, Stoffregen, Clemens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3293714/
https://www.ncbi.nlm.nih.gov/pubmed/22244076
http://dx.doi.org/10.1186/1471-2407-12-14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3293714/
https://www.ncbi.nlm.nih.gov/pubmed/22244076
http://dx.doi.org/10.1186/1471-2407-12-14

Ejemplares similares